A Pharmacokinetic Study to Assess the Influence of Simultaneous CYP3A4 and P-glycoprotein Inhibition on E7080 Pharmacokinetics Following Single Dose Oral Administration of 5 mg E7080 to Healthy Volunteers
Clinical trial NCT02198170 · COMPLETED
Trial details
- NCT number
- NCT02198170
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2011-06-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.